Last reviewed · How we verify
PK and Drug Interaction Study of Utidelone Plus Capecitabine in Patients With Advanced Breast Cancer
This trial is an open, multi-center, phase Ic clinical study on the pharmacokinetics and drug interactions of utidelone injection combined with capecitabine in patients with recurrent and metastatic breast cancer. The purpose of this trial is: 1. To evaluate the pharmacokinetic characteristics of continuous intravenous administration of utidelone. 2. To evaluate the drug interaction of utidelone and capecitabine.
Details
| Lead sponsor | Beijing Biostar Pharmaceuticals Co., Ltd. |
|---|---|
| Phase | PHASE1 |
| Status | COMPLETED |
| Enrolment | 16 |
| Start date | Thu Oct 15 2020 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Fri Feb 19 2021 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Advanced and Metastatic Breast Cancer
Interventions
- Utidelone Injection; capecitabine
- Utidelone
Countries
China